144 related articles for article (PubMed ID: 18458643)
21. Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis.
Saadoun D; Rosenzwajg M; Landau D; Piette JC; Klatzmann D; Cacoub P
Blood; 2008 Jun; 111(11):5334-41. PubMed ID: 18292291
[TBL] [Abstract][Full Text] [Related]
22. [Kidney involvement in mixed cryoglobulinemia: which treatment?].
Cacoub P
Presse Med; 2012 Mar; 41(3 Pt 1):254-9. PubMed ID: 22192935
[TBL] [Abstract][Full Text] [Related]
23. Rituximab in cryoglobulinemic peripheral neuropathy.
Cavallo R; Roccatello D; Menegatti E; Naretto C; Napoli F; Baldovino S
J Neurol; 2009 Jul; 256(7):1076-82. PubMed ID: 19263187
[TBL] [Abstract][Full Text] [Related]
24. Rituximab in mixed cryoglobulinemia: increased experience and perspectives.
De Vita S; Quartuccio L; Fabris M
Dig Liver Dis; 2007 Sep; 39 Suppl 1():S122-8. PubMed ID: 17936213
[TBL] [Abstract][Full Text] [Related]
25. Noninfectious mixed cryoglobulinaemic glomerulonephritis and monoclonal gammopathy of undetermined significance: a coincidental association?
Flavell AL; Fullinfaw RO; Smith ER; Holt SG; Finlay MJ; Barbour TD
BMC Nephrol; 2020 Jul; 21(1):293. PubMed ID: 32703171
[TBL] [Abstract][Full Text] [Related]
26. The use of monoclonal antibody (rituximab) in the treatment of type II mixed cryoglobulinemia.
Rego TC; Massumoto CM; Batista RS; Moura LH; Soares LM; Gomes AP
Braz J Infect Dis; 2007 Feb; 11(1):174-5. PubMed ID: 17625752
[TBL] [Abstract][Full Text] [Related]
27. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.
Saadoun D; Delluc A; Piette JC; Cacoub P
Curr Opin Rheumatol; 2008 Jan; 20(1):23-8. PubMed ID: 18281853
[TBL] [Abstract][Full Text] [Related]
28. [Hepatitis C virus-related cryoglobulinemic vasculitis with renal involvement: current possibilities of treatment].
Gordovskaia NB; Kozlovskaia LV; Milovanova SIu; Ignatova TM; Korotchaeva IuV
Ter Arkh; 2013; 85(6):78-84. PubMed ID: 23866603
[TBL] [Abstract][Full Text] [Related]
29. Cryoglobulinemic glomerulonephritis: clinical presentation and histological features, diagnostic pitfalls and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy.
Rossi D; Sciascia S; Fenoglio R; Ferro M; Baldovino S; Kamgaing J; Ventrella F; Kalikatzaros I; Viziello L; Solfietti L; Barreca A; Roccatello D
Minerva Med; 2021 Apr; 112(2):162-174. PubMed ID: 33198442
[TBL] [Abstract][Full Text] [Related]
30. Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients.
Basse G; Ribes D; Kamar N; Mehrenberger M; Esposito L; Guitard J; Lavayssière L; Oksman F; Durand D; Rostaing L
Transplantation; 2005 Dec; 80(11):1560-4. PubMed ID: 16371926
[TBL] [Abstract][Full Text] [Related]
31. [Cryoglobulinemia].
Cacoub P; Sène D; Saadoun D
Rev Med Interne; 2008 Mar; 29(3):200-8. PubMed ID: 18242787
[TBL] [Abstract][Full Text] [Related]
32. Cryoglobulinaemia type III with severe neuropathy and immune complex glomerulonephritis: remission after plasmapheresis and rituximab.
Braun A; Neumann T; Oelzner P; Hein G; Gröne HJ; Ziemer M; Wolf G
Rheumatol Int; 2008 Mar; 28(5):503-6. PubMed ID: 17924113
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of rituximab in severe and mild abdominal vasculitis in the course of mixed cryoglobulinemia.
Quartuccio L; Petrarca A; Mansutti E; Pieroni S; Calcabrini L; Avellini C; Zignego A; De Vita S
Clin Exp Rheumatol; 2010; 28(1 Suppl 57):84-7. PubMed ID: 20412709
[TBL] [Abstract][Full Text] [Related]
34. The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia.
Muro K; Toda N; Yamamoto S; Yanagita M
Intern Med; 2021 Feb; 60(4):583-589. PubMed ID: 32999232
[TBL] [Abstract][Full Text] [Related]
35. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?
Cacoub P; Delluc A; Saadoun D; Landau DA; Sene D
Ann Rheum Dis; 2008 Mar; 67(3):283-7. PubMed ID: 17644544
[TBL] [Abstract][Full Text] [Related]
36. Essential mixed cryoglobulinemia type III with leukocytoclastic vasculitis: remission by rituximab.
Baerlecken NT; Schmidt RE
Clin Rheumatol; 2013 Mar; 32 Suppl 1():S19-20. PubMed ID: 20213127
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease.
Fabrizi F; Plaisier E; Saadoun D; Martin P; Messa P; Cacoub P
Am J Kidney Dis; 2013 Apr; 61(4):623-37. PubMed ID: 23102733
[TBL] [Abstract][Full Text] [Related]
38. Treatment of hepatitis C-virus-related glomerulonephritis.
Kamar N; Rostaing L; Alric L
Kidney Int; 2006 Feb; 69(3):436-9. PubMed ID: 16514428
[TBL] [Abstract][Full Text] [Related]
39. ANCA, infectious endocarditis, glomerulonephritis and cryoglobulinemic vasculitis.
Lamprecht P; Gadola S; Schnabel A; Gross WL
Clin Nephrol; 1998 Jun; 49(6):389-90. PubMed ID: 9696437
[No Abstract] [Full Text] [Related]
40. Cold agglutinin disease and cryoglobulinemia.
Gertz MA
Clin Lymphoma; 2005 Mar; 5(4):290-3. PubMed ID: 15794868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
